Syringes Market Size & Share 2024 – 2032

Syringes Market Size

The global syringes market size was valued at USD 19.6 billion in 2023 and is estimated to grow at a CAGR of 10.9% from 2024 to 2032. A syringe is a type of medical equipment that is utilized to insert or withdraw fluid from the body.

It comprises a plunger that controls the flow of the fluid, a barrel in which the liquid is stored, and a nozzle or needle through which the liquid is finely injected into the body. There are ranges of syringes such as pre-filled, safety, and conventional syringes. Furthermore, they are important in administering specific quantities of medication including vaccines, anesthesia, and insulin in a safe manner within the healthcare settings.

 

The syringes market is experiencing significant growth driven by the increasing incidence of chronic disorders like diabetes and cancer. According to the International Diabetes Federation (IDF) report from 2021, there were around 537 million individuals aged between 20 and 79 suffering from diabetes in 2021, with a projection of reaching 643 million by 2030 and nearly 783 million by 2045. The global increase in diabetes has raised the demand for insulin syringes for daily blood sugar monitoring. Furthermore, the advancement in injectable therapies and cancer treatment is shifting the demand towards specialized syringes designed for precise dosing and low contamination risks.


Moreover, the increased demand from chronic conditions and the growing elderly population further enables high, safe, and easy to operate injection devices to continuously grow the market. Coupled with the shifts towards home healthcare also encourages the use of syringes as patients look for more affordable options to treatment outside clinical facilities.
 

Syringes Market Trends

Innovative designs, like safety- engineered syringes with retractable or shielded needles, help alleviate the chance of needle-stick injuries to health providers and patients. Additionally, features like dose accuracy, enhanced ergonomics, and ease of use are especially important for holistic drug delivery systems in chronic disease management. The need for advanced syringes and needles has increased globally with the drive for increased safety and efficacy within the healthcare systems as well as the priority for increased standards.
 

• For instance, in June 2021, single-use safety needles were released in collaboration with U.K based Stare Syringes by Hindustan Syringes and Medical Devices (HMD). These safety needles are on the market under the brand name Dispojekt Needle. They are designed to prevent sharps injuries and can fit onto standard Dispo Van and KOJAK Auto Disable syringes. Disable syringes which automatically disables after use, reduce the risk of blood-borne infection.
   
• This innovation contributed significantly to preventing infections and strengthening patient safety protocols in treatment settings and also increased sales of the syringes drastically.
   
• Moreover, the advanced safety syringes have high production costs, cost of infection at the injection site is great, and Strict production standards may curtail growth of the market.
   

These factors may limit the affordability and availability of such products, especially in developing parts of the world where affordable alternatives are necessary.
 

Syringes Market Analysis

Based on preparation, the global market is segmented into ready to use (RTU) and ready to sterilize (RTS). The RTU segment dominated the market and is anticipated to grow at 11.1% CAGR over the forecast period.
 

• Cost effectiveness of RTU segment is driven by the convenience and effectiveness for healthcare providers and patients.
   
• Most RTU syringes are prefilled, eliminating the need for manual dosing preparation step and decreasing chances of dosage errors and bacteriological contamination.
   
• Their easy-to-use construction increases patient compliance in chronic disease management because they are easy to use.
   
• In addition, there is an increased trend in the use of home healthcare RTU syringes enabling a rise in demand as they are easy and safe to use independently.
   
• This is expected to reinforce the RTU segment, encourage innovation and boost market share.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the syringes market is categorized into small molecules, biologics, and diagnostics. The biologics segment accounted for the highest market share of 54.7% in 2023.
 

• Rising demand for biologic drug treatment for chronic and autoimmune disorders, coupled with a rise in approved biologics, are strong drivers of the biologics segment.
   
• For instance, in Q1 2014, over 24 new or expanded indications were approved by the U.S. Food and Drug Administration (FDA) alongside the European Medicines Agency (EMA) along with eight new oncology agents. These approvals covered around 14 types of solid tumors and four hematologic malignancies.
   
• Notably, nearly half of these approvals were granted to biologics or biosimilars, including 14 new biologics, about half of which were programmed cell death protein 1 (PD-1) inhibitors along with three biosimilars.
   
• The increasing approvals of the biologics and oncology treatments is contributing to better prospects of syringe demand as these new therapies will need specially designed syringes to ensure safety and effectiveness while administering the injection.
   
• Biologics include monoclonal antibodies, therapeutic proteins, and vaccines require sophisticated delivery method through syringes.
   
• In addition, the trend toward personalized medicine emphasizes the importance of effective delivery systems which strengthens further the prominent position of the biologics segment within the market.
   

Based on material, the global syringes market is categorized into glass, and plastic/ polymers. The plastic/ polymers segment accounted for the highest revenue of USD 13.1 billion in 2023.
 

• The lightweight, inexpensive, and flexible properties of plastic/polymer materials account for its prominence.
   
• Materials like polypropylene and polyethylene are used for constructing single-use syringes due to their strength and chemical resistance.
   
• Due to the greater risk of spread of infections as well as the need for safety, there has been higher demand for plastic disposable syringes as they can be safely disposed after use.
   
• Innovation in polymer technology has led to the production of a specific type of syringe for different purposes, thus supporting the dominance of the plastic category in the industry.
   

Based on size, the syringes market is categorized into 1 ml, 1 ml - 2 ml, 3 ml - 5 ml, 6 ml - 10 ml, 10 - 20 ml, 20 - 30 ml, and >30 ml. The 3 ml - 5 ml segment accounted for the highest market share in 2023 and is projected to reach USD 10.8 billion by 2032.
 

• 1 ml to 2 ml syringes are popular because of their common usage in clinical and home healthcare services.
   
• These syringes play a critical role in the vaccination drives, diabetes care, and many chronic disease managements as they are extensively used for injectable medicines, especially for insulin, and other drugs.
   
• Their compact design enables accurate dosing which minimizes the patient’s discomfort during injection.
   
• These factors have resulted in increased demand for 1ml – 2 ml syringes as the number of diabetes patients and vaccination campaigns continue to increase.
   
• Moreover, the convenience and versatility further reinforce its position in the market.
   

Based on end use, the syringes market is categorized into hospitals & clinics, pharma & biotech companies, contract development and manufacturing organizations (CDMOs), diagnostic laboratories, and other end users. The hospitals & clinics segment is projected to dominate the market throughout the analysis period.
 

• The dominance of hospitals and clinics is due to the high volume of injections received in these places.
   
• Syringes are used by health services in several tasks including vaccination, blood sample collection, and medicine, along with intravenous infusion.
   
• The growing number of patients seeking treatment and the emergence of more chronic diseases, we need more and more modern hospitals and clinics. The demand of syringes will continually increase.
   
• Furthermore, the need for disposable syringes is further enhanced by rigorous infection control measures as well as safety protocols, which will solidify the segment’s market share.
   

In 2023, the U.S. held a leading position in the North American syringes market and is projected to maintain this dominance throughout the forecast period, with a CAGR of 10.6%.
 

• The U.S. leadership was asserted to its well-established healthcare facilities, strong R&D efforts, and high demand for medical devices.
   
• In addition, the country's high investment in R&D driving innovation in syringe technologies systems, such as prefilled and safety-engineered syringes enabling patient safety and treatment outcomes has further contributed to the country's growth.
   
• Furthermore, increase in vaccination and diagnosed chronic diseases, there has been boost in market growth.
   
• For instance, the American Cancer Society had estimated that in 2021 there were more than 17 million cancer patients in the U.S. By 2024 it is anticipated that 2 million new cases every year will be reported across the nation. These facts and figures showcase the heavy burden of cancer and the treatment gap in the country, which includes biological therapies and other treatment methods, that has led to an increase in cancer directed therapies. As a result, management of injectable drug delivery systems has increased.
   

• In addition, the government policies and easy reimbursement procedures will boost the growth of the market, making the US more competitive in the North American region.
   

Germany held a prominent position in the Europe syringes market.
 

• Germany was one of the most advanced users of syringes in Europe. As a country, Germany is aided by its efficient healthcare system and the growing usage of technology in medicine. The nation can cultivate advanced veterinary practices like safety-engineered and prefilled syringes because of its strong pharmaceutical sector and focus on R&D.
   
• German’s have high standards when it comes to the quality of health care they receive and patient safety, which results in high rates of adoption of disposable and efficient drug delivery systems.
   
• Also, chronic diseases are increasingly becoming more prevalent, and the population is getting older, which further increases the size of the market in Germany and its position in Europe.
   

China holds the highest share of 32.8% in the Asia Pacific syringes industry in 2023.
 

• China's market leadership in the Asia Pacific is attributed to its greater medical infrastructure and needs for more medical devices.
   
• With better economic growth, the country can spend more on health care which leads to more hospitals and clinics being built that need syringes for vaccinations and drugs.
   
• In addition, China has a large population and many chronic diseases which will help the market grow.
   

Brazil accounted for the highest revenue in the Latin American syringes market.
 

• Brazil's prominence is attributed to the expansion of the healthcare infrastructure and the increasing demand for medical supplies.
   
• The growing demand for syringes in hospitals, clinics and other healthcare facilities coupled with growing vaccination campaigns and focus on chronic disease management has further stimulated the demand.
   
• In addition, the improvement in population healthcare access and an increase in the adoption of disposable and safety-engineered syringes has led to a rise in population.
   

Saudi Arabia is poised to grow at a significant growth rate in the Middle East and African syringes market
 

• Funding from government expects to project a rapid growth in Saudi Arabia driven by rising healthcare spending and continued investment in medical infrastructure.
   
• In addition, the Vision 2030 initiative by the Saudi government aims at enhancing healthcare services and improving patient outcomes which will include upgrading the sector’s infrastructure.
   
• The increase in demand for syringes can also be attributed to the increase in chronic diseases and emphasis on increasing immunization programs.
   

Syringes Market Share

The competitive landscape of the market is intense as leading companies focus on product development, safety, and geographical diversification. Dominant corporations hold market shares because they have incorporated a variety of products, such as insulin and vaccine syringes. Most of the firms are investing in improving safety and ease of use through technologies such as retractable needles to prevent needlestick injuries. Furthermore, strategic alliances and mergers enable them to have a stronger foothold on the market, while new entrants concentrate on low-cost and green products to supply the increasing need in developing areas.
 

Syringes Market Companies

Few of the prominent players operating in the syringes industry include:

• Becton, Dickinson and Company (BD)
• Cardinal Health
• Corning
• Daikyo Seiko
• DWK Life Sciences
• Gerresheimer AG
• ICU Medical
• Mitsubishi Gas Chemical Company
• Nipro
• SCHOTT Pharma (SCHOTT Group)
• Shandong Province Medicinal Glass
• SHIOTANI GLASS
• Terumo
• Weigao Group
• West Pharmaceutical Services
   

USPs of the companies

• The companies are focusing on strong presence with extensive product portfolio
• Offers diverse range of tailored syringes solution for therapeutic application
• Robust distribution in developed and emerging countries
   

Syringes Industry News

• In March 2024, BD and ten23 health, a human-centric and sustainable strategic CDMO, entered into a partnership to innovate tracking methods for prefillable syringes utilizing RFID technology. This collaboration aimed to enhance the efficiency and reliability of syringe tracking, ultimately improving patient safety and inventory management.
   
• In November 2023, Terumo India launched an Insulin Syringe, a sterile delivery device designed for patients needing regular insulin injections. This innovation aimed to enhance patient comfort and improve therapy compliance, setting new standards in diabetes care.
   

The syringes market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and volume in Units from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Preparation

• Ready to use (RTU)
• Ready to sterilize (RTS)

Market, By Application

• Small molecules
• Biologics
• Diagnostics

Market, By Material

• Glass
• Plastic/ polymers

Market, By Size

• 1 ml
• 1 ml - 2 ml
• 3 ml - 5 ml
• 6 ml - 10 ml
• 10 - 20 ml
• 20 - 30 ml
• >30 ml

Market, By End use

• Hospitals & clinics
• Pharma & biotech companies
• Contract development and manufacturing organizations (CDMOs)
• Diagnostic laboratories

• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • Saudi Arabia
  • South Africa
  • UAE